Multicomponent Tablet Formulation Technology Platform

Multicomponent tablets are formulations ingeniously crafted by combining two or more active ingredients. This innovative combination not only amplifies efficacy and safety, but also diminishes side effects and lessens patients' psychological aversion to multiple drug intake, thereby improving medication compliance. Additionally, it contributes to reducing the risk of developing drug resistance, which holds particular significance in the treatment of infectious diseases.

Our Distinctive Edge and Expertise

UBI Pharma Inc. proudly presents a comprehensive dual-layer tablet development platform. This platform not only accommodates multicomponent formulations but also exhibits a distinctive capability to mitigate interactions among active ingredients.

Within our laboratory, a kilogram-scale solid dosage manufacturing line stands equipped with specialized machinery, including granulators, fluid bed processors, coaters, tablet presses, and film coaters. This infrastructure not only facilitates the establishment of prescription-scale trial conditions during the research phase, but also seamlessly integrates them with mass production process parameters, ensuring an unbroken continuum from concept to commercialization.

Supported by a RD team with extensive experience in the development of both generic and 505(b)(2) products, UBI Pharma Inc. is primed to deliver the highest level of service. Partner with us  to embark the journey that reshapes the pharmaceutical innovation.